A Phase III, Open-label, multicenter, non-comparative 12 month study to evaluate the efficacy and safety of Triptorelin Acetate in children with central precocious puberty

Trial Profile

A Phase III, Open-label, multicenter, non-comparative 12 month study to evaluate the efficacy and safety of Triptorelin Acetate in children with central precocious puberty

Completed
Phase of Trial: Phase III

Latest Information Update: 28 Apr 2017

At a glance

  • Drugs Triptorelin (Primary)
  • Indications Precocious puberty
  • Focus Therapeutic Use
  • Most Recent Events

    • 28 Apr 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top